Skip to main content
HHS Logo U.S. Department of Health & Human Services NIH logo National Institutes of Health
Home
  • Site Map
  • |
  • Contact
  • Research
    • Pre-Clinical Innovation
      • Improving the Drug Development Process
      • Repurposing Drugs
      • Testing & Predictive Models
      • Core Technologies
      Clinical Innovation
      • Clinical and Translational Science Awards (CTSA) Program
      • Rare Diseases Clinical Research Network (RDCRN)
      • Patient Registries
      • Clinical Research Toolbox
      Strategic Alliances
      • Alliances at NCATS
      • Licensing Opportunities
      • Forms & Model Agreements
      • Work with Strategic Alliances
      • Ask an Astronaut: Biomedical Science Edition
      • Biomedical Research and Public Health Collaborations with NASA
      • History of NIH and NASA Collaborations
      • NIH-NASA Activities
      Patient/Community Engagement & Health Information
      • Genetic and Rare Diseases Information Center
      • NCATS Toolkit for Patient-Focused Therapy Development
      • Undiagnosed Diseases Program
      • Clinical Trials at NIH
      Expertise & Resources
      • Pre-Clinical Research Toolbox
      • Clinical Research Toolbox
      NCATS' Role in the NIH HEAL Initiative
      • About NCATS’ Role in the NIH HEAL Initiative
      • Fiscal Year 2019 Funded Projects and Prizes
      • NIH HEAL Initiative Funding & Collaboration Opportunities Led by NCATS
      NCATS Programs & Initiatives
  • Funding & Notices
    • Open Funding Opportunities
      • Closed Opportunities
      • Conference Grant Information
      • NCATS Program-Specific Funding Information
      • NCATS Rare Diseases Are Not Rare! Challenge Prize Details
      Small Business Opportunities
      • About Small Business Opportunities
      • SBIR & STTR Research Priorities
      • Small Business Funding
      • Small Business Resources
      Funding Policy & Scientific Review
      • Funding Policy
      • PUBLIC NOTICE
      • Scientific Review
      • Cures Acceleration Network
      Grantee Information
      • Submission of Prior Approval Requests
      • Prior NIH Approval of Human Subjects Research Frequently Asked Questions
  • News & Media
    • News & Events
      • Releases & Announcements
      • Media Coverage
      • Grantee & Partner News
      • Events
      Stories & Publications
      • Features and Briefs
      • Scientific Publications
      • NCATS E-Newsletter
      Media Resources
      • Photos
      • Audio
      • Videos
      Connect with NCATS
  • About Translation
    • Translational Science Education & Training
      • Translational Science Education Resources
      • Translational Science Training at NCATS
      • Translational Science Training at Partner Institutions
      Translational Science Spectrum
      Issues in Translation
      • Artificial/Machine Intelligence
      • Clinical Research Efficiency
      • Collaboration and Partnerships
      • Data Transparency and Release
      • De-Risking Therapeutic Development
      • Predictive Efficacy and Toxicology
      Drug Discovery, Development and Deployment Maps
      Translational Science Skills
  • About NCATS
    • Center Overview
      • About the Center
      • Director’s Corner
      • NCATS Staff Profiles
      • NCATS Strategic Plan
      NCATS Programs & Initiatives
      • 3-D Tissue Bioprinting Program
      • A Specialized Platform for Innovative Research Exploration (ASPIRE)
      • Assay Development and Screening Technology (ADST)
      • Biomedical Data Translator
      • Bridging Interventional Development Gaps (BrIDGs)
      • Chemistry Technology
      • Discovering New Therapeutic Uses for Existing Molecules
      • Genetic and Rare Diseases Information Center (GARD)
      • Matrix Combination Screening
      • NCATS Chemical Genomics Center (NCGC)
      • A Specialized Platform for Innovative Research Exploration (ASPIRE)
      • NIH Common Fund Programs
      • Rare Diseases Registry Program (RaDaR)
      • Tissue Chip for Drug Screening
      • Toxicology in the 21st Century (Tox21)
      • Trans-NIH RNAi Facility (TNRF)
      • Therapeutics for Rare and Neglected Diseases (TRND)
      Work with NCATS
      • Contribute to NCATS Research
      Advisory Groups
      • NCATS Advisory Council
      • Cures Acceleration Network (CAN) Review Board
      • Council Concept Clearances
  • Research
    • Pre-Clinical Innovation
    • Clinical Innovation
    • Strategic Alliances
    • Patient/Community Engagement & Health Information
    • Expertise & Resources
    • NCATS' Role in the NIH HEAL Initiative
    • NCATS Programs & Initiatives
  • Funding & Notices
    • Open Funding Opportunities
    • Small Business Opportunities
    • Funding Policy & Scientific Review
    • Grantee Information
  • News & Media
    • News & Events
    • Stories & Publications
    • Media Resources
    • Connect with NCATS
  • About Translation
    • Translational Science Education & Training
    • Translational Science Spectrum
    • Issues in Translation
    • Drug Discovery, Development and Deployment Maps
    • Translational Science Skills
  • About NCATS
    • Center Overview
    • NCATS Programs & Initiatives
    • Work with NCATS
    • Advisory Groups
  1. Home
  2. About NCATS
  3. NCATS Programs & Initiatives
  4. Chemistry Technology
  5. Chemistry Technology Projects
  6. Active Chemistry Technology Projects
  • About Chemistry Technology
  • Chemistry Technology Scientific Capabilities
  • Work with Chemistry Technology
  • Chemistry Technology Projects
    • Active Chemistry Technology Projects
    • Completed Chemistry Technology Projects

Active Chemistry Technology Projects

Click on the links below to view active Chemistry Technology projects:

  • Development of a Novel Inhibitor of Fumarate Hydratase in Mycobacterium Tuberculosis
  • Development of a Small Molecule Inhibitor of the ß-O-Linked-N-Acetylglucosamine Transferase (OGT)
  • Development of an Activator of the Pyruvate Kinase Isoform M2 (PKM2)
  • Development of Dual-Acting IRAK/FLT3 Inhibitors for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS)
  • Development of the αllbß3 Antagonist RUC-4 for the Treatment of Myocardial Infarction (MI) and Congestive Heart Failure
  • Development of (2R,6R)-Hydroxynorketamine as a Treatment for Depression

Contact

Nicole Spears (link sends e-mail)

Last updated: 10-19-2018

▲ Back to top
  • Connect with us:

  • Facebook Icon
  • LinkedIn Icon
  • Twitter Icon
  • YouTube Icon
  • Flickr Icon
  • Address Book Icon
  • E-Mail Icon
  • NCATS Home
  • Site Map
  • Privacy Notice
  • Comment Policy
  • Disclaimer
  • Accessibility
  • FOIA
  • OIG

If you have problems viewing PDF files, download the latest version of Adobe Reader

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS), 6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966